NCT04417673View on ClinicalTrials.gov

Living With Sickle Cell Disease in the COVID-19 Pandemic

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

May 18, 2022

Study Completion Date

May 18, 2022

Conditions
IsolationAnxietyHealth Care UtilizationSickle Cell DiseasePain
Trial Locations (1)

20892

National Human Genome Research Institute (NHGRI), Bethesda

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT04417673 - Living With Sickle Cell Disease in the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter